Rare diseases
Investigational molecules
Locations
Back to Spain1 637 clinical trials in Sevilla, Spain across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in SpainEnsayosClinicos.es(opens in a new tab)Study of Chemotherapy vs. Nivolumab for Patients with Resectable Non-Small Cell Lung Cancer
SpainStudy on Belapectin for Preventing Esophageal Varices in Patients with NASH Cirrhosis
SpainStudy on Tiragolumab and Atezolizumab for Patients with Resected Stage IIB-IIIB Non-Small Cell Lung Cancer After Chemotherapy
SpainStudy of Alectinib and Platinum-Based Chemotherapy for Patients with Resected Stage Ib to IIIa ALK-Positive Non-Small Cell Lung Cancer
SpainStudy of Temocillin and Meropenem for Patients with Infections Caused by Resistant Enterobacteriaceae
SpainStudy of MK-4280A (Favezelimab and Pembrolizumab) for Patients with Metastatic Colorectal Cancer After Previous Treatment
SpainSpainStudy on the Safety and Effectiveness of Human Alpha1-Proteinase Inhibitor for Preventing Graft-Versus-Host Disease in Patients Undergoing Hematopoietic Cell Transplant.
SpainStudy on the Effectiveness and Safety of RO7198457 and Pembrolizumab for Patients with Untreated Advanced Melanoma
SpainStudy of Gilteritinib and Chemotherapy for Children, Adolescents, and Young Adults with Relapsed or Refractory Acute Myeloid Leukemia with FLT3 Mutation
SpainStudy of Trastuzumab Deruxtecan for Patients with HER2-Low Breast Cancer and New or Worsening Brain Metastases
SpainStudy Comparing Trastuzumab Deruxtecan and Trastuzumab Emtansine for Patients with Advanced HER2-Positive Breast Cancer
SpainThe busiest research cities in the country
What the registry says about research in the country
Innovative research focusing on Type 1 Diabetes management and weight-related conditions, evaluating new therapeutic approaches for glycemic control and metabolic health.
Studies aim to improve treatment outcomes for patients with complex metabolic conditions.
Advanced clinical trials examining treatments for Multiple Sclerosis and neurodegenerative disorders, including pioneering research in Frontotemporal Dementia and Parkinson's disease.
Research focuses on developing targeted treatments for various neurological conditions.
Comprehensive vaccine development programs targeting Influenza, Cytomegalovirus, and meningococcal infections, with emphasis on preventive medicine.
Studies aim to enhance vaccine efficacy and immune response across different age groups.
Groundbreaking studies in cancer treatment, including research on bladder cancer and mantle cell lymphoma, exploring combination therapies and targeted treatments.
Focus on developing innovative approaches to improve cancer treatment outcomes.
Clinical investigations into Psoriatic Arthritis and inflammatory conditions, evaluating novel therapeutic approaches and treatment combinations.
Research aims to develop more effective treatments for chronic autoimmune conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
